Role of RANKL/RANK in primary and secondary breast cancer. - Wikidata - awgldk - TriplyDB

Role of RANKL/RANK in primary and secondary breast cancer.

Role of RANKL/RANK in primary and secondary breast cancer.

http://www.wikidata.org/entity/Q37241255

about

Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain Acidic microenvironment and bone pain in cancer-colonized bone RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.STC1 expression is associated with tumor growth and metastasis in breast cancer.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients.Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.

P2860

Q28085753-05976A7C-114E-45EE-B153-7B052619D1CD Q35575632-DD1530EB-9A0F-46E1-82FB-A4445E3E320C Q36362955-30BA8974-2F77-447D-8419-F754A658A319 Q37660315-BA11717F-6A10-458E-8D3A-4D843CEF5CD7 Q38700342-C0E45E52-BAD6-4F8F-B4B7-FE4CAD6840B1 Q38940981-46A22AC5-945A-45C3-947E-4A418B25FCF2 Q41036251-4E3CFAD6-A311-43A4-A23A-6DAF315680E0 Q47169220-07A7C595-EF76-47BC-A93C-ED1D9B0A2AE7 Q49299129-15E548B2-8B1D-4803-89CA-2A8595BAB5D5 Q50080460-AD971892-69F5-42C6-A9C6-F6FCBD6FD5ED Q50437697-9C20D471-4B93-4795-95A7-CA5D56323DF5

P2860

Role of RANKL/RANK in primary and secondary breast cancer.

http://www.wikidata.org/entity/Q37241255

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of RANKL/RANK in primary and secondary breast cancer.

@en

Role of RANKL/RANK in primary and secondary breast cancer.

@nl

type

label

Role of RANKL/RANK in primary and secondary breast cancer.

@en

Role of RANKL/RANK in primary and secondary breast cancer.

@nl

prefLabel

Role of RANKL/RANK in primary and secondary breast cancer.

@en

Role of RANKL/RANK in primary and secondary breast cancer.

@nl

P1433

Q37241255-6C1502BB-D44E-4607-ACEE-512EB4DF1529

P1476

Q37241255-0D739693-693D-4EC3-9C52-61F8BE0DE12D

P2093

Q37241255-01E909D1-44AF-4DDF-98B1-F94A5B1522EC

Q37241255-6368E680-AD57-4057-88E3-4A18EA6B49E4

Q37241255-F1D52331-27B3-4EEE-8C4B-E420C8B9229E

P2860

Q37241255-02077A23-C5D0-4A95-B453-A2AD5DD20C59

Q37241255-0303307D-BD20-4EDD-AD95-D691B4C51986

Q37241255-0E280C77-AD3B-4C06-9184-A7530EE11E7A

Q37241255-12A7FB46-09E6-4CC4-A127-46ABFF4BE45B

Q37241255-162B9AA3-4DA0-40B3-8DB1-74B14D4D3538

Q37241255-271CC6C9-8DEA-4151-9FE6-3478E006FD8F

Q37241255-2C76BFFD-C46D-4100-B62D-106AE67010F0

Q37241255-3594B793-F8E2-4298-A5FC-05664CBB0573

Q37241255-3A2A0AEA-50E8-4D36-BB2B-EEF1DF96EFFA

Q37241255-3B6D4E79-1919-43B8-98A2-63052816434E

P304

Q37241255-9F82C95D-3097-4CBA-B329-6F6EE3EFBEA9

P31

Q37241255-1CE6E5AC-D0D6-41EB-B62C-B8E015CA8BE9

P356

Q37241255-3341AB5A-0CE3-4A17-9F46-8E82169D6FD4

P433

Q37241255-B3DD270C-5A9E-4518-B820-3E26066327C7

P478

Q37241255-EF5E2277-7CDE-4687-A677-AD4A52FD4BF3

P577

Q37241255-B1F04C7B-2DC4-4783-9EB1-FDA339E61B1E

P5875

Q37241255-315EADAB-AA74-4254-8DF9-8F3C86DFF499

P698

Q37241255-96B605AE-0CDB-42CF-9502-BA5CBB225246

P932

Q37241255-645A27B5-AEF4-4DE0-AC5F-0881F49C9511

P356

P1433

World journal of orthopedics

P1476

Role of RANKL/RANK in primary and secondary breast cancer.

@en

P2093

Kenji Hata

http://www.w3.org/2001/XMLSchema#string

Soichi Tanaka

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Yoneda

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

Structure and activity of the acid-sensing ion channels

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

Bone cancer pain and the role of RANKL/OPG

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats

P304

178-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5312/WJO.V4.I4.178

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258066826

http://www.w3.org/2001/XMLSchema#string

P698

24147253

http://www.w3.org/2001/XMLSchema#string

P932

3801237

http://www.w3.org/2001/XMLSchema#string